Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1

Conditions

Breast Neoplasms 57Pancreatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 20Neoplasms 17Neoplasm Metastasis 11Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Ovarian Neoplasms 8Melanoma 7Head and Neck Neoplasms 6Breast Neoplasms, Male 6Adenocarcinoma 6Urinary Bladder Neoplasms 5Inflammatory Breast Neoplasms 5Carcinoma 5Sarcoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Diseases 4Fallopian Tube Neoplasms 4Cholangiocarcinoma 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Adenocarcinoma 3Esophageal Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Digestive System Neoplasms 3Digestive System Diseases 3

Interventions

Cisplatin 27Cetuximab 17Radiotherapy 14Carboplatin 14pembrolizumab 11Paclitaxel 11Drug Therapy 8Radiotherapy, Intensity-Modulated 7Nivolumab 7Fluorouracil 7Erlotinib Hydrochloride 7Radiation 6Docetaxel 5130-nm albumin-bound paclitaxel 5Panitumumab 4Chemoradiotherapy 3Capecitabine 3Bevacizumab 3Albumin-Bound Paclitaxel 3Afatinib 3selinexor 2figitumumab 2Restraint, Physical 2Radiosurgery 2Methotrexate 2Lapatinib 2Everolimus 2Esophagectomy 2Cyclophosphamide 2zalutumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Carcinoma, Squamous Cell × Albumin-Bound Paclitaxel × Clear all
NCT03174275 2026-02-23

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

UNC Lineberger Comprehensive Cancer Center

Phase 2 Active not recruiting
39 enrolled 8 charts
GastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Esophageal Neoplasms, Laryngeal Neoplasms, Lip Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT02027428 2020-08-17

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Celgene

Phase 3 Completed
427 enrolled 29 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡